Katherine J. Turner
Plus aucun poste en cours
Profil
Katherine J.
Turner was Vice President of Research & Development for NUCRYST Pharmaceuticals Corp.
from June 2007 to April 30, 2008.
She joined NUCRYST Pharmaceuticals as Vice President of Research in June 2006.
Prior to NUCRYST, Dr. Turner served as Vice President of Validation Biology for Biogen Idec, Inc. from July 2001 to November 2005.
She was Vice President of Immunology and Hemostasis for Genetics Institute and Wyeth Pharmaceuticals.
She received a BS from the University of Sussex, UK and an MS and a PhD in Biochemistry from Virginia Polytechnic Institute & State University.
She completed post-doctoral research at Brandeis University and London University.
Anciens postes connus de Katherine J. Turner
| Sociétés | Poste | Fin |
|---|---|---|
NUCRYST Pharmaceuticals Corp.
 NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | Directeur Technique/Scientifique/R&D | 30/04/2008 |
| BIOGEN INC. | Corporate Officer/Principal | 01/11/2005 |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | - |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formation de Katherine J. Turner
| University of Sussex | Undergraduate Degree |
| Virginia Polytechnic Institute & State University | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | Health Technology |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
